ABRI — Miami, Florida

ABRI is a clinical research site located in Miami, Florida, United States 33155.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

ABRI has participated in 1 clinical trials.

Therapeutic areas: Attention Deficit/Hyperactivity Disorder.

Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Miami

Browse all research sites in Florida · View every site in Miami

• University of Miami Hospital and Clincs/SCCC
• University of Miami Miller School of Medicine Schiff Center for Liver Disease
• University Of Miami Leonard M Mille School Of Medicine SCCC
• Baptist Health South Miami Hospital
• University of Miami Hosptial
• University of Miami Dept. of Neurology
• ISCI/University of Miami Miller School of Medicine
• The Miami Project to Cure Paralysis/ University of Miami
• University of Miami School of Medicine/Miami Project to Cure Paralysis
• RANGER: University of Miami
• University of Miami /ID# 258396
• Holtz's Children's Hospital- University of Miami/Jackson Memorial Hospital

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for ABRI?

ABRI has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has ABRI conducted?

ABRI has 1 clinical trials on record. Their work covers Attention Deficit/Hyperactivity Disorder.

Is ABRI accredited by Crixeo Clinical Trials?

ABRI has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about ABRI?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.